PPAR-α Activation Mediates Innate Host Defense through Induction of TFEB and Lipid Catabolism.

Targeting NADPH oxidase as a therapeutic strategy for inflammatory diseases.

Activities of LCB01-0371, a novel         oxazolidinone, against Mycobacterium abscessus.

Host-directed therapeutics as novel angle for tuberculosis treatment.

Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo.

The targeted delivery of the c-Src peptide complexed with schizophyllan to macrophages inhibits polymicrobial sepsis and ulcerative colitis in mice.

Peptide inhibition of p22phox and Rubicon interaction as a therapeutic strategy for septic shock.

Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody.

RNAi-mediated silencing of TNF-α converting enzyme to        down-regulate soluble TNF-α production for treatment of acute and chronic colitis.

Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome.